Iron-refractory iron deficiency anemia (IRIDA)

Hematology/Oncology Clinics of North America

Volumn 28, Issue 4, 2014, Pages 637-652

  Heeney, Matthew M ^a   Finberg, Karin E ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hepcidin; Inherited iron deficiency; Iron refractory iron deficiency anemia; Matriptase 2; TMPRSS6

Indexed keywords

GLUCOCORTICOID; HEPCIDIN; IRON; MATRIPTASE; MATRIPTASE 2; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

DIFFERENTIAL DIAGNOSIS; GENE; GENE MUTATION; HUMAN; IRON ABSORPTION; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; IRON REFRACTORY IRON DEFICIENCY ANEMIA; IRON THERAPY; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; TMPRSS6 GENE; ANEMIA, IRON-DEFICIENCY; GENETICS;

ANEMIA, IRON-DEFICIENCY; DIAGNOSIS, DIFFERENTIAL; HUMANS;

EID: 84904723183     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2014.04.009     Document Type: Review

References (78)

1. Cook J.D., Barry W.E., Hershko C., et al. Iron kinetics with emphasis on iron overload. Am J Pathol 1973, 72(2):337-344.
2. Chen C., Paw B.H. Cellular and mitochondrial iron homeostasis in vertebrates. Biochim Biophys Acta 2012, 1823(9):1459-1467.
3. Ward D.M., Kaplan J. Ferroportin-mediated iron transport: expression and regulation. Biochim Biophys Acta 2012, 1823(9):1426-1433.
4. Ganz T. Systemic iron homeostasis. Physiol Rev 2013, 93(4):1721-1741.
5. Buchanan G.R., Sheehan R.G. Malabsorption and defective utilization of iron in three siblings. J Pediatr 1981, 98(5):723-728.
6. Pearson H.A., Lukens J.N. Ferrokinetics in the syndrome of familial hypoferremic microcytic anemia with iron malabsorption. J Pediatr Hematol Oncol 1999, 21:412-417.
7. Mayo M.M., Samuel S.M. Iron deficiency anemia due to a defect in iron metabolism: a case report. Clin Lab Sci 2001, 14(3):135-138.
8. Brown A.C., Lutton J.D., Pearson H.A., et al. Heme metabolism and in vitro erythropoiesis in anemia associated with hypochromic microcytosis. Am J Hematol 1988, 27(1):1-6.
9. Hartman K.R., Barker J.A. Microcytic anemia with iron malabsorption: an inherited disorder of iron metabolism. Am J Hematol 1996, 51(4):269-275.
10. Andrews N.C. Iron deficiency: lessons from anemic mice. Yale J Biol Med 1997, 70(3):219-226.
11. Galanello R., Cau M., Melis M.A., et al. Studies of NRAMP2, transferrin receptor and transferrin genes as candidate genes for human hereditary microcytic anemia due to defective iron absorption and utilization. Blood 1998, 92(Suppl 1):669a. [abstract].
12. Finberg K.E., Heeney M.M., Campagna D.R., et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 2008, 40(5):569-571.
13. De Falco L., Sanchez M., Silvestri L., et al. Iron refractory iron deficiency anemia. Haematologica 2013, 98(6):845-853.
14. Melis M.A., Cau M., Congiu R., et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 2008, 93(10):1473-1479.
15. Ramsay A.J., Quesada V., Sanchez M., et al. Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms. Hum Mol Genet 2009, 18(19):3673-3683.
16. Baker R.D., Greer F.R., Committee on Nutrition American Academy of Pediatrics Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics 2010, 126(5):1040-1050.
17. Hartman KR, Finberg KE, Merino ME. Iron resistant iron deficiency anemia: long term follow-up of 5 patients [abstract]. ASPHO Annual Meeting Abstracts. San Diego, 2009.
18. Melis M.A., Cau M., Congiu R., et al. Identification of a gene involved in hereditary microcytic anemia due to defective iron absorption in a Sardinian family. Eur J Hum Genet 2007, 15(S1):261. [abstract].
19. Du X., She E., Gelbart T., et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science 2008, 320(5879):1088-1092.
20. Guillem F., Lawson S., Kannengiesser C., et al. Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. Blood 2008, 112(5):2089-2091.
21. Kemna E.H., Tjalsma H., Podust V.N., et al. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem 2007, 53(4):620-628.
22. Ganz T., Olbina G., Girelli D., et al. Immunoassay for human serum hepcidin. Blood 2008, 112(10):4292-4297.
23. Velasco G., Cal S., Quesada V., et al. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J Biol Chem 2002, 277(40):37637-37646.
24. Ramsay A.J., Hooper J.D., Folgueras A.R., et al. Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica 2009, 94(6):840-849.
25. Stirnberg M., Maurer E., Horstmeyer A., et al. Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface. Biochem J 2010, 430(1):87-95.
26. Sanders A.J., Webb S.L., Parr C., et al. The type II transmembrane serine protease, matriptase-2: possible links to cancer?. Anticancer Agents Med Chem 2010, 10(1):64-69.
27. Folgueras A.R., de Lara F.M., Pendas A.M., et al. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood 2008, 112(6):2539-2545.
28. Meynard D., Babitt J.L., Lin H.Y. The liver: conductor of systemic iron balance. Blood 2014, 123(2):168-176.
29. Kautz L., Meynard D., Monnier A., et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 2008, 112(4):1503-1509.
30. Andriopoulos B., Corradini E., Xia Y., et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 2009, 41(4):482-487.
31. Meynard D., Kautz L., Darnaud V., et al. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 2009, 41(4):478-481.
32. Silvestri L., Pagani A., Nai A., et al. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 2008, 8(6):502-511.
33. Babitt J.L., Huang F.W., Wrighting D.M., et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 2006, 38(5):531-539.
34. Papanikolaou G., Samuels M.E., Ludwig E.H., et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004, 36(1):77-82.
35. Truksa J., Gelbart T., Peng H., et al. Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6. Br J Haematol 2009, 147(4):571-581.
36. Finberg K.E., Whittlesey R.L., Fleming M.D., et al. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Blood 2010, 115(18):3817-3826.
37. Lenoir A., Deschemin J.C., Kautz L., et al. Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp6. Blood 2011, 117(2):647-650.
38. Lakhal S., Schodel J., Townsend A.R., et al. Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis. J Biol Chem 2011, 286(6):4090-4097.
39. Maurer E., Gutschow M., Stirnberg M. Matriptase-2 (TMPRSS6) is directly up-regulated by hypoxia inducible factor-1: identification of a hypoxia-responsive element in the TMPRSS6 promoter region. Biol Chem 2012, 393(6):535-540.
40. Zhang A.S., Anderson S.A., Wang J., et al. Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein. Blood 2011, 117(5):1687-1699.
41. Meynard D., Vaja V., Sun C.C., et al. Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. Blood 2011, 118(3):747-756.
42. Meynard D., Sun C.C., Wu Q., et al. Inflammation regulates TMPRSS6 expression via STAT5. PLoS One 2013, 8(12):e82127.
43. Silvestri L., Guillem F., Pagani A., et al. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia. Blood 2009, 113(22):5605-5608.
44. Edison E.S., Athiyarath R., Rajasekar T., et al. A novel splice site mutation c.2278 (-1) G>C in the TMPRSS6 gene causes deletion of the substrate binding site of the serine protease resulting in refractory iron deficiency anaemia. Br J Haematol 2009, 147(5):766-769.
45. Tchou I., Diepold M., Pilotto P.A., et al. Haematologic data, iron parameters and molecular findings in two new cases of iron-refractory iron deficiency anaemia. Eur J Haematol 2009, 83(6):595-602.
46. De Falco L., Totaro F., Nai A., et al. Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA). Hum Mutat 2010, 31(5):E1390-E1405.
47. Altamura S., D'Alessio F., Selle B., et al. A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA. Biochem J 2010, 431(3):363-371.
48. Beutler E., Van Geet C., te Loo D.M., et al. Polymorphisms and mutations of human TMPRSS6 in iron deficiency anemia. Blood Cells Mol Dis 2010, 44(1):16-21.
49. Cuijpers M.L., Wiegerinck E.T., Brouwer R., et al. Iron deficiency anaemia due to a matriptase-2 mutation. Ned Tijdschr Geneeskd 2010, 154:A1038. [in Dutch].
50. Choi H.S., Yang H.R., Song S.H., et al. A novel mutation Gly603Arg of TMPRSS6 in a Korean female with iron-refractory iron deficiency anemia. Pediatr Blood Cancer 2012, 58(4):640-642.
51. Guillem F., Kannengiesser C., Oudin C., et al. Inactive matriptase-2 mutants found in IRIDA patients still repress hepcidin in a transfection assay despite having lost their serine protease activity. Hum Mutat 2012, 33(9):1388-1396.
52. Pellegrino R.M., Coutinho M., D'Ascola D., et al. Two novel mutations in the TMPRSS6 gene associated with iron-refractory iron-deficiency anaemia (IRIDA) and partial expression in the heterozygous form. Br J Haematol 2012, 158(5):668-672.
53. Jaspers A., Caers J., Le Gac G., et al. A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia (IRIDA). Br J Haematol 2013, 160(4):564-565.
54. Khuong-Quang D.A., Schwartzentruber J., Westerman M., et al. Iron refractory iron deficiency anemia: presentation with hyperferritinemia and response to oral iron therapy. Pediatrics 2013, 131(2):e620-e625.
55. Yimaz Keskin E., Sal E., de Falco L., et al. Is the acronym IRIDA acceptable for slow responders to iron in the presence of TMPRSS6 mutations?. Turk J Pediatr 2013, 55(5):479-484.
56. Lehmberg K., Grosse R., Muckenthaler M.U., et al. Administration of recombinant erythropoietin alone does not improve the phenotype in iron refractory iron deficiency anemia patients. Ann Hematol 2013, 92(3):387-394.
57. Nai A., Pagani A., Silvestri L., et al. Increased susceptibility to iron deficiency of Tmprss6-haploinsufficient mice. Blood 2010, 116(5):851-852.
58. The international HapMap project. Nature 2003, 426(6968):789-796. The International HapMap Consortium.
59. An integrated map of genetic variation from 1,092 human genomes. Nature 2012, 491(7422):56-65. The 1000 Genomes Project Consortium.
60. Benyamin B., McRae A.F., Zhu G., et al. Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. Am J Hum Genet 2009, 84(1):60-65.
61. Benyamin B., Ferreira M.A., Willemsen G., et al. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat Genet 2009, 41(11):1173-1175.
62. Chambers J.C., Zhang W., Li Y., et al. Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels. Nat Genet 2009, 41(11):1170-1172.
63. Ganesh S.K., Zakai N.A., van Rooij F.J., et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet 2009, 41(11):1191-1198.
64. Soranzo N., Spector T.D., Mangino M., et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009, 41(11):1182-1190.
65. Tanaka T., Roy C.N., Yao W., et al. A genome-wide association analysis of serum iron concentrations. Blood 2010, 115(1):94-96.
66. Nai A., Pagani A., Silvestri L., et al. TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals. Blood 2011, 118(16):4459-4462.
67. Traglia M., Girelli D., Biino G., et al. Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations. J Med Genet 2011, 48(9):629-634.
68. Galesloot T.E., Geurts-Moespot A.J., den Heijer M., et al. Associations of common variants in HFE and TMPRSS6 with iron parameters are independent of serum hepcidin in a general population: a replication study. J Med Genet 2013, 50(9):593-598.
69. Finberg K.E., Whittlesey R.L., Andrews N.C. Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice. Blood 2011, 117(17):4590-4599.
70. Nai A., Pagani A., Mandelli G., et al. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of beta-thalassemia. Blood 2012, 119(21):5021-5029.
71. Valenti L., Fracanzani A.L., Rametta R., et al. Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis. J Hepatol 2012, 57(6):1319-1325.
72. Pelusi S., Girelli D., Rametta R., et al. The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis. BMC Nephrol 2013, 14:48.
73. Valenti L., Rametta R., Dongiovanni P., et al. The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease. PLoS One 2012, 7(11):e48804.
74. Camaschella C. How I manage patients with atypical microcytic anaemia. Br J Haematol 2013, 160(1):12-24.
75. Cau M., Galanello R., Giagu N., et al. Responsiveness to oral iron and ascorbic acid in a patient with IRIDA. Blood Cells Mol Dis 2012, 48(2):121-123.
76. Nie N., Shi J., Shao Y., et al. A novel tri-allelic mutation of TMPRSS6 in iron-refractory iron deficiency anaemia with response to glucocorticoid. Br J Haematol 2014, [Epub ahead of print].
77. Gross S.J., Stuart M.J., Swender P.T., et al. Malabsorption of iron in children with iron deficiency. J Pediatr 1976, 88(5):795-799.
78. Molla A.M., Verpoorten C., Eggermont E. The intestinal mucosa of children with iron deficiency. Acta Paediatr Belg 1973, 27(1):5-12.